Report from enhanced safety surveillance of two influenza vaccines (Vaxigrip and Intanza 15 μg) in two European countries during influenza season 2016/17 and comparison with 2015/16 season

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions